Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m6A RNA methylation in ocular melanoma

Abstract Background Diversified histone deacetylation inhibitors (HDACis) have demonstrated encouraging outcomes in multiple malignancies. N6‐methyladenine (m6A) is the most prevalent messenger RNA modification that plays an essential role in the regulation of tumorigenesis. Howbeit, an in‐depth und...

詳細記述

書誌詳細

出版年:	Cancer Communications
主要な著者:	Ai Zhuang, Xiang Gu, Tongxin Ge, Shaoyun Wang, Shengfang Ge, Peiwei Chai, Renbing Jia, Xianqun Fan
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2023-11-01
主題:	epigenetics histone deacetylation inhibitors melanoma N6‐methyladenine histone‐RNA crosstalk
オンライン･アクセス:	https://doi.org/10.1002/cac2.12471